- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT07774767
Effects of a Flipped-Learning Empowering Leadership Program on Nurse Leaders, Staff, and Residents in Long-Term Care Facilities
maanantai 17. elokuuta 2026 päivittänyt: I-Hui-Chen
Flipped Learning for Leader Empowering Leadership in Aged Care: A Pilot Cluster Quasi-Experimental Study
This pilot cluster quasi-experimental study tested a 12-week empowering-leadership training program delivered through flipped learning to nurse leaders in residential long-term care facilities, compared with a conventional brochure-based approach.
Six facilities in central Taiwan participated: two (one public, one private) received the flipped-learning program for their leaders, and four (one public, three private) served as controls.
The study examined effects at three levels: nurse leaders' own empowering leadership behaviors and facility-level nursing staff retention/turnover and resident hospitalization rates; nursing staff's perceptions of their leader's empowering behaviors, burnout, psychological empowerment, and job satisfaction; and residents' health status, quality of life, and satisfaction with care.
Tutkimuksen yleiskatsaus
Tila
Valmis
Opintotyyppi
Interventio
Ilmoittautuminen (Todellinen)
287
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.
Opiskelupaikat
-
-
-
Taichung, Taiwan
- Residential Long-Term Care Facilities
-
-
Osallistumiskriteerit
Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Aikuinen
- Vanhempi Aikuinen
Hyväksyy terveitä vapaaehtoisia
Ei
Kuvaus
Inclusion Criteria:
Nurse Leaders:
- Age ≥ 20 years
- Employed as nursing director, supervisor, or head
- Employed at the facility for more than 6 months
- Willing to participate and able to give informed consent
Nursing Staff:
- Registered nurse, licensed practical nurse, or nursing assistant
- Employed at the facility for ≥ 3 months
- Age ≥ 20 years
- Informed consent given
Residents:
- Resided at the facility for ≥ 3 months
- Mini-Mental State Examination (MMSE) score ≥ 24
- No severe hearing impairment
- Not terminally ill
- Written informed consent given (or via authorized representative as applicable)
Exclusion Criteria:
Nurse Leaders:
- Indicated intent to leave the position within the next 6 months
Opintosuunnitelma
Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Terveyspalvelututkimus
- Jako: Ei satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Flipped Learning Intervention
2 residential long-term care facilities (1 public, 1 private): 10 nurse leaders, 40 nursing staff, 100 residents.
Nurse leaders received a 12-week flipped-learning empowering leadership program.
|
A 12-week, 24-hour empowering leadership program (one 2-hour module per week).
Each week, a 60-minute instructional video was posted for asynchronous pre-class learning, followed by a 1-hour face-to-face session (small-group discussion, case studies, brief presentations, practical exercises), with instructor summary.
Post-class activities included reflection and assignments.
|
|
Active Comparator: Conventional Learning / Control
4 residential long-term care facilities (1 public, 3 private): 11 nurse leaders, 40 nursing staff, 86 residents.
Nurse leaders received a printed brochure with identical content, without structured flipped-learning sessions.
|
Nurse leaders in the control group received a printed brochure covering the same empowerment/empowering-behavior content as the intervention group, without structured flipped-learning sessions.
The research team maintained regular contact to answer questions but provided no additional training.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Leader Empowerment Behavior
Aikaikkuna: Baseline and immediately post-intervention (approximately 12 weeks)
|
Leader Empowerment Behavior Scale (Chinese version), a 27-item self-report measure across 5 subscales (extending meaning of work, engaging staff in decision-making, expressing confidence, encouraging goal achievement, providing autonomy).
Each item rated on a 7-point Likert scale (1=strongly disagree, 7=strongly agree); total score range 27-189, with higher scores indicating more empowering leadership behavior (better outcome).
Cronbach's α=0.71; test-retest r=0.83.
|
Baseline and immediately post-intervention (approximately 12 weeks)
|
|
Staff-Perceived Leader Empowering Behavior
Aikaikkuna: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
Modified version of the Leader Empowerment Behavior Scale, a 27-item measure completed by nursing staff about their leader, across 5 subscales.
Each item rated on a 7-point Likert scale; total score range 27-189, with higher scores indicating more empowering behavior as perceived by staff (better outcome).
Cronbach's α=0.85; test-retest r=0.71.
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Occupational Burnout
Aikaikkuna: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
Occupational Burnout Inventory Scale, a 21-item self-report measure across 4 subscales (personal burnout, work-related burnout, client-related burnout, over-commitment to work).
Each item rated on a 5-point Likert scale; total score range 21-105, with higher scores indicating greater burnout (worse outcome).
Cronbach's α=0.80; test-retest reliability=0.78.
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
|
Psychological Empowerment
Aikaikkuna: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
Spreitzer's Psychological Empowerment Scale, a 12-item self-report measure across 4 subscales (meaning, competence, self-determination, impact).
Each item rated on a 5-point Likert scale; total score range 12-60, with higher scores indicating greater psychological empowerment (better outcome).
Cronbach's α=0.87; test-retest reliability=0.82.
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
|
Job Satisfaction
Aikaikkuna: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
Minnesota Satisfaction Questionnaire Short Form, a 20-item self-report measure.
Each item rated on a 5-point Likert scale; total score range 20-100, with higher scores indicating greater job satisfaction (better outcome).
Cronbach's α=0.88; test-retest reliability=0.84.
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
|
Job Stress
Aikaikkuna: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
Single-item self-report measure ("Do you often feel very stressed at work?"), rated on a 5-point Likert scale; score range 1-5, with higher scores indicating greater job stress (worse outcome).
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
|
Health Status (SF-36)
Aikaikkuna: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
36-Item Short Form Health Survey (SF-36), across 8 domains (physical functioning, role limitations due to physical health, role limitations due to emotional problems, pain, emotional well-being, social functioning, energy, general health).
Each domain scored 0-100, with higher scores indicating better health status (better outcome).
Cronbach's α=0.78-0.90;
test-retest reliability=0.86-0.91.
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
|
Quality of Life (WHOQOL-BREF)
Aikaikkuna: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
World Health Organization Quality of Life Questionnaire, Abbreviated Version (WHOQOL-BREF), across 4 domains (physical health, psychological health, social relationships, environmental health).
Domain scores range from 4 to 20, with higher scores indicating better quality of life (better outcome).
Cronbach's α=0.80-0.88;
test-retest reliability=0.90-0.95.
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
|
Care Quality / Customer Satisfaction
Aikaikkuna: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
Customer Satisfaction Scale, a 25-item self-report measure across 4 subscales (comfort/cleanliness, nursing care, food services, facility care/services).
Each item rated on a 5-point Likert scale; total score range 25-125, with higher scores indicating greater satisfaction with care quality (better outcome).
Cronbach's α=0.94; test-retest reliability=0.75.
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
|
Nursing Staff Retention Rate
Aikaikkuna: 12-month period prior to the intervention (baseline) and 12-month period beginning approximately 1 month after the 12-week intervention was completed (follow-up)
|
12-month period prior to the intervention (baseline) and 12-month period beginning approximately 1 month after the 12-week intervention was completed (follow-up)
|
|
|
Nursing Staff Turnover Rate
Aikaikkuna: 12-month period prior to the intervention (baseline) and 12-month period beginning approximately 1 month after the 12-week intervention was completed (follow-up)
|
12-month period prior to the intervention (baseline) and 12-month period beginning approximately 1 month after the 12-week intervention was completed (follow-up)
|
|
|
Resident Hospitalization Rate
Aikaikkuna: 12-month period prior to the intervention (baseline) and 12-month period beginning approximately 1 month after the 12-week intervention was completed (follow-up)
|
12-month period prior to the intervention (baseline) and 12-month period beginning approximately 1 month after the 12-week intervention was completed (follow-up)
|
Yhteistyökumppanit ja tutkijat
Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.
Sponsori
Opintojen ennätyspäivät
Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan julkisella verkkosivustolla.
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Keskiviikko 1. elokuuta 2018
Ensisijainen valmistuminen (Todellinen)
Torstai 30. toukokuuta 2019
Opintojen valmistuminen (Todellinen)
Lauantai 30. toukokuuta 2020
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Torstai 13. elokuuta 2026
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Maanantai 17. elokuuta 2026
Ensimmäinen Lähetetty (Todellinen)
Keskiviikko 19. elokuuta 2026
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Keskiviikko 19. elokuuta 2026
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Maanantai 17. elokuuta 2026
Viimeksi vahvistettu
Lauantai 1. elokuuta 2026
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muut tutkimustunnusnumerot
- CRREC-105-002
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Ei
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Ei
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .